240 related articles for article (PubMed ID: 25559208)
1. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Paloque L; Hutter S; Castera-Ducros C; Laget M; Rault S; Valentin A; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2015 May; 23(10):2377-86. PubMed ID: 25846065
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
5. Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
Pedron J; Boudot C; Hutter S; Bourgeade-Delmas S; Stigliani JL; Sournia-Saquet A; Moreau A; Boutet-Robinet E; Paloque L; Mothes E; Laget M; Vendier L; Pratviel G; Wyllie S; Fairlamb A; Azas N; Courtioux B; Valentin A; Verhaeghe P
Eur J Med Chem; 2018 Jul; 155():135-152. PubMed ID: 29885575
[TBL] [Abstract][Full Text] [Related]
6. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
[TBL] [Abstract][Full Text] [Related]
7. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
Agarwal KC; Sharma V; Shakya N; Gupta S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
[TBL] [Abstract][Full Text] [Related]
11. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent.
Yousuf M; Mukherjee D; Dey S; Chatterjee S; Pal A; Sarkar B; Pal C; Adhikari S
Bioorg Med Chem Lett; 2018 Apr; 28(6):1056-1062. PubMed ID: 29478704
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]